Skip to main content

Research

Overview

Our research centers on engineering bioactive materials to treat Type 1 diabetes (T1D), specifically in polymeric surface engineering of cells, fabrication of three-dimensional scaffolds, controlled oxygen and drug release, and the design of new approach methodologies (NAMs) to study pathology and screen therapeutics.. Our translational research portfolio spans material development, extensive evaluation of preclinical models, and clinical translation.

schematic of the beta cell niche showing all the different cells and vascular network

Main Research Areas